Stent for arterialization of the coronary sinus and retrograde perfusion of the myocardium
OwnerEric C. Martininventor
Life of this patent
Estimating the term…
Loading patent…
OwnerEric C. Martininventor
Estimating the term…
The present invention concerns a novel stent and a method for communicating oxygenated blood directly from the left ventricle to the coronary sinus to provide retrograde perfusion to the myocardium. The stent is placed substantially within the coronary sinus with its trailing end protruding into the right atrium and the leading end protruding into the left ventricle. The stent has a smaller passageway at or near the trailing (right ventricular) end and at or near the leading (left ventricle) end, and has a covering at the trailing end. The smaller passageway and the cover at the trailing end to promote retrograde flow into the venous system of the hear and specifically the myocardium of the left ventricle and to reduce a significant left-to-right shunt.
A stent for supplying oxygenated blood to heart tissue retrogradely through the coronary sinus comprising:
A method for directly supply oxygenated blood from the left ventricle to heart tissue via the coronary sinus using a stent comprising:
Dependencies are inferred from the claim text.